ArticleJournal of hypertension2025
Associations of insulin resistance surrogate with resistant hypertension and the severity of hypertension in the chronic kidney disease population.
Article in Journal of hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Vicious Cycle of Diabetic Kidney Disease, Vitamin D Deficiency, and Arterial Hypertension.Healthcare (Basel, Switzerland) · 2026Review
- A Cross-Ethnicity Validated Machine Learning Model for the Progression of Chronic Kidney Disease in Individuals over 50 Years Old.Journal of clinical medicine · 2026Article
- Associations of Visceral Adiposity Index and Body Roundness Index with chronic kidney disease in a Hakka population: mediating effect of blood pressure.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExtensive research has explored the relationship between the triglyceride-glucose (TyG) index and hypertension, yet the associations of the TyG index with resistant hypertension and the severity of hypertension in the chronic kidney disease (CKD) population remain unclear.
methodsWe analyzed data from 3944 CKD participants in the NHANES survey (1999-2020). Binary and ordered logistic regression analyses assessed the TyG index's impact on hypertension categories (uncontrolled, resistant, and refractory hypertension) and severity.
resultsHigher TyG index quartiles were significantly associated with higher odds of hypertension categories after adjustments for covariates. Specifically, the odds ratios (ORs) for the highest quartile were 1.68 (1.27-2.22) for uncontrolled hypertension, 2.24 (1.41-3.58) for resistant hypertension, and 2.17 (1.18-3.99) for refractory hypertension compared to the lowest quartile. The continuous TyG index showed similar trends, with ORs of 1.28 (1.10-1.49), 1.54 (1.23-1.94), and 1.40 (0.97-2.01), respectively. Higher TyG index levels were also linked to greater hypertension severity. The ORs (Q2, 3, 4 vs. Q1) were 1.29 (1.01-1.65), 1.37 (1.10-1.72), and 1.80 (1.40-2.32), respectively. Each one-unit increase in the TyG index raised the OR for hypertension severity to 1.34 (1.17-1.53).
conclusionThis study demonstrated that an elevated TyG index is significantly associated with higher odds of uncontrolled, resistant, and refractory hypertension, as well as greater severity of hypertension. The findings underscored the utility of the TyG index as a valuable biomarker for evaluating resistant hypertension risk and hypertension severity among patients with CKD in community settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.